Planned PMA Pathway Modeled On Existing Accelerated Programs
This article was originally published in The Gray Sheet
Executive Summary
CDRH’s plans for a specialized pathway for high-risk PMA devices that address unmet medical needs will be modeled on the drug center’s recently established breakthrough therapy pathway, and also the device center’s Innovation Pathway.